PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Product Testing of Immunological Medicinal Products for Veterinary Use, Division of Veterinary Medicine, Paul-Ehrlich-Institut, D-63225 Langen, Germany.\', \'German Center for Infection Research, D-63225 Langen, Germany.\', \'Department of Microbiology & Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.\', \'Division of Virology, Paul-Ehrlich-Institut, D-63225 Langen, Germany.\', \'Pathogenesis of Respiratory Viruses, Division of Veterinary Medicine, Paul-Ehrlich-Institut, D-63225 Langen, Germany.\', \'Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.\', \'Rapidly Emerging Antiviral Drug Discovery Initiative, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.\', \'Product Testing of Immunological Medicinal Products for Veterinary Use, Division of Veterinary Medicine, Paul-Ehrlich-Institut, D-63225 Langen, Germany; Michael.Muehlebach@pei.de.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1073/pnas.2014468117
?:hasPublicationType
?:journal
  • Proceedings of the National Academy of Sciences of the United States of America
is ?:pmid of
?:pmid
?:pmid
  • 33257540
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.092
?:rankingScore_hIndex
  • 675
is ?:relation_isRelatedTo_publication of
?:title
  • A highly immunogenic and effective measles virus-based Th1-biased COVID-19 vaccine.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33257540>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33257540>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all